Literature DB >> 15673435

Differential expression of two NMDA receptor interacting proteins, PSD-95 and SynGAP during mouse development.

Karen Porter1, Noboru H Komiyama, Tania Vitalis, Peter C Kind, Seth G N Grant.   

Abstract

Patterns of neural activity mediated by N-methyl-D-aspartate (NMDA) receptors are known to play important roles in development of the central nervous system. However, the signalling pathways downstream from NMDA receptors that are critical for normal neuronal development are not yet clearly understood. NMDA receptors interact with various signalling proteins via scaffolding proteins, which are important in adult neuronal and behavioural plasticity. For example, the NR2B subunits of the NMDA receptor interact with postsynaptic density 95 (PSD-95), which in turn binds to synaptic ras GTPase-activating protein (SynGAP). Interestingly, the developmental phenotype of mice carrying null mutations in these genes differ. NR2B and SynGAP homozygote mice die within the first week of birth whereas PSD-95 homozygote mice survive to adulthood. We therefore examined the expression patterns of PSD-95 and SynGAP genes from embryonic stages to adult using lacZ (beta-galactosidase) marker gene knock-in mice. Dramatic changes of expression were observed throughout development in brain and other tissues. Although SynGAP binds PSD-95, both genes had distinct, as well as overlapping expression. SynGAP expression peaked at times of synaptogenesis and developmental plasticity in contrast to PSD-95, which was expressed throughout the brain from early embryonic stages. Furthermore, SynGAP showed a more spatially restricted pattern as illustrated by its restriction to forebrain in contrast to PSD-95, which was also found in mid- and hindbrain. These data support the model that synaptic signalling complexes are heterogeneous and individual components show temporal and spatial specificity during development.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15673435     DOI: 10.1111/j.1460-9568.2005.03874.x

Source DB:  PubMed          Journal:  Eur J Neurosci        ISSN: 0953-816X            Impact factor:   3.386


  19 in total

Review 1.  High throughput protein expression screening in the nervous system--needs and limitations.

Authors:  Chris N G Anderson; Seth G N Grant
Journal:  J Physiol       Date:  2006-06-22       Impact factor: 5.182

2.  SynGAP moves out of the core of the postsynaptic density upon depolarization.

Authors:  Y Yang; J-H Tao-Cheng; T S Reese; A Dosemeci
Journal:  Neuroscience       Date:  2011-06-26       Impact factor: 3.590

3.  Pathogenic SYNGAP1 mutations impair cognitive development by disrupting maturation of dendritic spine synapses.

Authors:  James P Clement; Massimiliano Aceti; Thomas K Creson; Emin D Ozkan; Yulin Shi; Nicholas J Reish; Antoine G Almonte; Brooke H Miller; Brian J Wiltgen; Courtney A Miller; Xiangmin Xu; Gavin Rumbaugh
Journal:  Cell       Date:  2012-11-09       Impact factor: 41.582

4.  Two knockdown models of the autism genes SYNGAP1 and SHANK3 in zebrafish produce similar behavioral phenotypes associated with embryonic disruptions of brain morphogenesis.

Authors:  Robert A Kozol; Holly N Cukier; Bing Zou; Vera Mayo; Silvia De Rubeis; Guiqing Cai; Anthony J Griswold; Patrice L Whitehead; Jonathan L Haines; John R Gilbert; Michael L Cuccaro; Eden R Martin; James D Baker; Joseph D Buxbaum; Margaret A Pericak-Vance; Julia E Dallman
Journal:  Hum Mol Genet       Date:  2015-04-16       Impact factor: 6.150

5.  Bipolar I disorder and schizophrenia: a 440-single-nucleotide polymorphism screen of 64 candidate genes among Ashkenazi Jewish case-parent trios.

Authors:  M Daniele Fallin; Virginia K Lasseter; Dimitrios Avramopoulos; Kristin K Nicodemus; Paula S Wolyniec; John A McGrath; Gary Steel; Gerald Nestadt; Kung-Yee Liang; Richard L Huganir; David Valle; Ann E Pulver
Journal:  Am J Hum Genet       Date:  2005-10-28       Impact factor: 11.025

6.  Reduced expression of the NMDA receptor-interacting protein SynGAP causes behavioral abnormalities that model symptoms of Schizophrenia.

Authors:  Xiaochuan Guo; Peter J Hamilton; Nicholas J Reish; J David Sweatt; Courtney A Miller; Gavin Rumbaugh
Journal:  Neuropsychopharmacology       Date:  2009-01-14       Impact factor: 7.853

7.  Identification of an individual with a SYGNAP1 pathogenic mutation in India.

Authors:  Vijaya Verma; Amit Mandora; Abhijeet Botre; James P Clement
Journal:  Mol Biol Rep       Date:  2020-10-22       Impact factor: 2.316

8.  Reduced cognition in Syngap1 mutants is caused by isolated damage within developing forebrain excitatory neurons.

Authors:  Emin D Ozkan; Thomas K Creson; Enikö A Kramár; Camilo Rojas; Ron R Seese; Alex H Babyan; Yulin Shi; Rocco Lucero; Xiangmin Xu; Jeffrey L Noebels; Courtney A Miller; Gary Lynch; Gavin Rumbaugh
Journal:  Neuron       Date:  2014-06-18       Impact factor: 17.173

Review 9.  Dysfunction of the corticostriatal pathway in autism spectrum disorders.

Authors:  Wei Li; Lucas Pozzo-Miller
Journal:  J Neurosci Res       Date:  2019-11-22       Impact factor: 4.164

10.  Convergence of Hippocampal Pathophysiology in Syngap+/- and Fmr1-/y Mice.

Authors:  Stephanie A Barnes; Lasani S Wijetunge; Adam D Jackson; Danai Katsanevaki; Emily K Osterweil; Noboru H Komiyama; Seth G N Grant; Mark F Bear; U Valentin Nägerl; Peter C Kind; David J A Wyllie
Journal:  J Neurosci       Date:  2015-11-11       Impact factor: 6.167

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.